Faricimab demonstrated noninferior vision gains and improved anatomical outcomes among patients with diabetic macular edema ...
The Sing IMT improved distance and near vision at 6 months in patients with late-stage age-related macular degeneration, with ...
The FDA has approved Susvimo (ranibizumab injection) for the treatment of patients with diabetic macular edema.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback